<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Toxicol Sci</journal-id>
<journal-id journal-id-type="iso-abbrev">Toxicol. Sci</journal-id>
<journal-id journal-id-type="publisher-id">toxsci</journal-id>
<journal-title-group>
<journal-title>Toxicological Sciences</journal-title>
</journal-title-group>
<issn pub-type="ppub">1096-6080</issn>
<issn pub-type="epub">1096-0929</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30715528</article-id>
<article-id pub-id-type="pmc">6484887</article-id>
<article-id pub-id-type="doi">10.1093/toxsci/kfz028</article-id>
<article-id pub-id-type="publisher-id">kfz028</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Manganese and Altered Metabolism in Human Neuroblastoma Cells</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Metabolomic Responses to Manganese Dose in SH-SY5Y Human Neuroblastoma Cells</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Fernandes</surname>
<given-names>Jolyn</given-names>
</name>
<xref ref-type="aff" rid="kfz028-aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chandler</surname>
<given-names>Joshua D</given-names>
</name>
<xref ref-type="aff" rid="kfz028-aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Ken H</given-names>
</name>
<xref ref-type="aff" rid="kfz028-aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Uppal</surname>
<given-names>Karan</given-names>
</name>
<xref ref-type="aff" rid="kfz028-aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hao</surname>
<given-names>Li</given-names>
</name>
<xref ref-type="aff" rid="kfz028-aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hu</surname>
<given-names>Xin</given-names>
</name>
<xref ref-type="aff" rid="kfz028-aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Go</surname>
<given-names>Young-Mi</given-names>
</name>
<xref ref-type="aff" rid="kfz028-aff1"></xref>
<xref ref-type="corresp" rid="kfz028-cor1"></xref>
<!--<email>ygo@emory.edu</email>-->
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jones</surname>
<given-names>Dean P</given-names>
</name>
<xref ref-type="aff" rid="kfz028-aff1"></xref>
</contrib>
</contrib-group>
<aff id="kfz028-aff1">Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, Emory University, Atlanta, Georgia</aff>
<author-notes>
<corresp id="kfz028-cor1">To whom correspondence should be addressed at Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, Emory University, 205P Whitehead Biomedical Research Building, 615 Michael Street, Atlanta, GA 30322. Fax: <fax>404-712-2974</fax>. E-mail: <email>ygo@emory.edu</email>.</corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>5</month>
<year>2019</year>
</pub-date>
<pub-date iso-8601-date="2019-01-31" pub-type="epub">
<day>31</day>
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>5</month>
<year>2020</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>169</volume>
<issue>1</issue>
<fpage>84</fpage>
<lpage>94</lpage>
<permissions>
<copyright-statement>© The Author(s) 2019. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="publisher-standard" xlink:href="https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model">
<license-p>This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (<ext-link ext-link-type="uri" xlink:href="https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model">https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model</ext-link>)</license-p>
</license>
</permissions>
<self-uri xlink:href="kfz028.pdf"></self-uri>
<abstract>
<title>Abstract</title>
<p>Manganese (Mn)-associated neurotoxicity has been well recognized. However, Mn is also an essential nutrient to maintain physiological function. Our previous study of human neuroblastoma SH-SY5Y cells showed that Mn treatment comparable to physiological and toxicological concentrations in human brain resulted in different mitochondrial responses, yet cellular metabolic responses associated with such different outcomes remain uncharacterized. Herein, SH-SY5Y cells were examined for metabolic responses discriminated by physiological and toxicological levels of Mn using high-resolution metabolomics (HRM). Before performing HRM, we examined Mn dose (from 0 to100 μM) and time effects on cell death. Although we did not observe any immediate cell death after 5 h exposure to any of the Mn concentrations assessed (0–100 μM), cell loss was present after a 24-h recovery period in cultures treated with Mn ≥ 50 μM. Exposure to Mn for 5 h resulted in a wide range of changes in cellular metabolism including amino acids (AA), neurotransmitters, energy, and fatty acids metabolism. Adaptive responses at 10 μM showed increases in neuroprotective AA metabolites (creatine, phosphocreatine, phosphoserine). A 5-h exposure to 100 µM Mn, a time before any cell death occurred, resulted in decreases in energy and fatty acid metabolites (hexose-1,6 bisphosphate, acyl carnitines). The results show that adjustments in AA metabolism occur in response to Mn that does not cause cell death while disruption in energy and fatty acid metabolism occur in response to Mn that results in subsequent cell death. The present study establishes utility for metabolomics analyses to discriminate adaptive and toxic molecular responses in a human <italic>in vitro</italic> cellular model that could be exploited in evaluation of Mn toxicity.</p>
</abstract>
<kwd-group kwd-group-type="author">
<kwd>adaptive response</kwd>
<kwd>cell metabolomics</kwd>
<kwd>metabolic pathway</kwd>
<kwd>neurotoxicity</kwd>
</kwd-group>
<funding-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">NIEHS</named-content>
<named-content content-type="funder-identifier">10.13039/100000066</named-content>
</funding-source>
<award-id>R01 ES023485</award-id>
<award-id>R21 ES025632</award-id>
<award-id>P30 ES019776</award-id>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">NIH</named-content>
<named-content content-type="funder-identifier">10.13039/100000002</named-content>
</funding-source>
<award-id>S10 OD018006</award-id>
</award-group>
</funding-group>
<counts>
<page-count count="11"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>